Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Shares Up 0.3% – Still a Buy?

Shares of Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQGet Free Report) shot up 0.3% during mid-day trading on Tuesday . The stock traded as high as $26.43 and last traded at $26.35. 17,996 shares changed hands during mid-day trading, an increase of 45% from the average session volume of 12,421 shares. The stock had previously closed at $26.27.

Invesco Nasdaq Biotechnology ETF Trading Up 0.3%

The company has a market capitalization of $42.69 million, a price-to-earnings ratio of 17.03 and a beta of 0.67. The company has a fifty day moving average of $24.52 and a 200-day moving average of $22.42.

Invesco Nasdaq Biotechnology ETF Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 26th. Investors of record on Monday, September 22nd were issued a $0.0958 dividend. This represents a $0.38 annualized dividend and a yield of 1.5%. The ex-dividend date was Monday, September 22nd. This is a positive change from Invesco Nasdaq Biotechnology ETF’s previous quarterly dividend of $0.03.

Institutional Investors Weigh In On Invesco Nasdaq Biotechnology ETF

Institutional investors have recently bought and sold shares of the company. Osaic Holdings Inc. boosted its holdings in Invesco Nasdaq Biotechnology ETF by 28.4% in the 2nd quarter. Osaic Holdings Inc. now owns 4,757 shares of the company’s stock worth $101,000 after buying an additional 1,052 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of Invesco Nasdaq Biotechnology ETF during the 2nd quarter worth approximately $149,000. IHT Wealth Management LLC acquired a new position in shares of Invesco Nasdaq Biotechnology ETF during the 2nd quarter worth approximately $211,000. Atria Investments Inc acquired a new position in shares of Invesco Nasdaq Biotechnology ETF during the 2nd quarter worth approximately $211,000. Finally, CreativeOne Wealth LLC acquired a new position in shares of Invesco Nasdaq Biotechnology ETF during the 1st quarter worth approximately $222,000.

Invesco Nasdaq Biotechnology ETF Company Profile

(Get Free Report)

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.

See Also

Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.